Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
H

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"

By Insights from 2023 ASH Annual Meeting FEATURING Hamza Hashmi
By Insights from 2023 ASH Annual Meeting FEATURING Hamza Hashmi
1,585 views
January 19, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Myeloma
17:13

Updates From ASH: The Evolving Role and Sequencing of Bispecifics an…

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

245 views
08:11

Triple-Class-Exposed R/R MM: Results From the KarMMa-3 Trial of Ide-…

Insights from 2023 ASH Annual Meeting

K. Patel

185 views
19:08

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

870 views
04:30

High-Risk NDMM: KarMMa-2 Extended Follow-Up - Ide-Cel in HR-NDMM Pat…

Insights from 2023 ASH Annual Meeting

M. Alsina

121 views
16:42

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

H. Hashmi

1.6K views
19:24

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - Incorpo…

Insights from 2023 ASH Annual Meeting

P. Richardson

760 views
06:44

ASH 2023 Insights: "Sonrotoclax Combined With Dexamethasone for the …

Insights from 2023 ASH Annual Meeting

H. Quach

71 views
06:55

ASH 2023 Insights: "Selinexor and Lenalidomide vs. Lenalidomide Main…

Insights from 2023 ASH Annual Meeting

H. Quach

28 views
05:03

ASH 2023 Insights: "Teclistamab in R/R MM - A Multi-Institutional Re…

Insights from 2023 ASH Annual Meeting

R. Chakraborty

236 views
15:13

ASH 2023 Insights: "Mezigdomide + Dex + Dara or Elo in Pts With R/R …

Insights from 2023 ASH Annual Meeting

P. Richardson

139 views
09:05

RRMM: Effects of Ide-Cel vs. Standard Regimens on HRQoL in Patients …

Insights from 2023 ASH Annual Meeting

M. Delforge

174 views
09:39

ASH 2023 Insights: "Impact of Dex Dose Strength on Outcomes in NDMM"

Insights from 2023 ASH Annual Meeting

R. Banerjee

227 views
04:37

ASH 2023 Insights: "Early Peripheral Blood MRD Status by NGS in Pts …

Insights from 2023 ASH Annual Meeting

B. Derman

105 views
06:19

Dara-KRd in NDMM Without ASCT: Final Analysis of a Ph2 Trial

Insights from 2023 ASH Annual Meeting

B. Derman

760 views
12:32

ASH 2023 Insights: "Early Benefits and Psychological Effects of Scre…

Insights from 2023 ASH Annual Meeting

S. Rögnvaldsson

74 views
10:03

ASH 2023 Insights: "MGUS and the Risk of Thrombotic Events - Results…

Insights from 2023 ASH Annual Meeting

S. Rögnvaldsson

21 views
10:53

ASH 2023 Insights: "RVd vs. RVd Plus ASCT in African Americans With …

Insights from 2023 ASH Annual Meeting

J. Zonder

12 views
17:46

ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies on a …

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

1.4K views
08:36

ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligible M…

Insights from 2023 ASH Annual Meeting

N. Joseph

463 views
10:06

ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extrame…

Insights from 2023 ASH Annual Meeting

D. Pan

52 views
06:14

Multiple Myeloma: Inflammatory Biomarkers and Outcomes CAR T-Cell Th…

Insights from 2023 ASH Annual Meeting

D. Pan

72 views
12:37

ASH 2023 Insights: "GMMG ReLApsE Trial - Salvage Auto Transplant & L…

Insights from 2023 ASH Annual Meeting

M. Bärtsch

63 views
10:23

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light…

Insights from 2023 ASH Annual Meeting

T. Einarsson Long

148 views
07:27

ASH 2023 Insights: "Dual Targeting of SLAMF-7 and CD38 - A Ph2 Study…

Insights from 2023 ASH Annual Meeting

B. Dhakal

405 views
03:14

ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor, Ixaz…

Insights from 2023 ASH Annual Meeting

J. Richter

126 views
08:51

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Specific A…

Insights from 2023 ASH Annual Meeting

R. Bansal

461 views
12:03

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed Stage…

Insights from 2023 ASH Annual Meeting

E. Kastritis

143 views
22:14

ASH 2023 Insights: "RW Safety & Efficacy of Teclistamab for Pts With…

Insights from 2023 ASH Annual Meeting

D. Dima

233 views
09:22

ASH 2023 Insights: "DREAMM-6 Trial Arm-A - Belantamab Mafodotin Comb…

Insights from 2023 ASH Annual Meeting

R. Popat

43 views
14:08

ASH 2023 Insights: "MonumenTAL-1 Study - Talquetamab in Pts With R/R…

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

144 views
06:06

ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D-Targ…

Insights from 2023 ASH Annual Meeting

S. Bal

69 views
04:55

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multi…

Insights from 2023 ASH Annual Meeting

S. Thorsteinsdottir

165 views
07:20

ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and Dexam…

Insights from 2023 ASH Annual Meeting

O. Nadeem

92 views
10:36

ASH 2023 Insights: "Immuno-PRISM Study of Bispecific Antibodies in H…

Insights from 2023 ASH Annual Meeting

O. Nadeem

98 views
11:55

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy & Safe…

Insights from 2023 ASH Annual Meeting

O. Landgren

284 views